Next |
home / stock / ifrx / ifrx message board
Subject | By | Source | When |
---|---|---|---|
Closing of offering, here comes first stop $6.25 | Gator44 | investorshub | 04/18/2023 2:25:38 PM |
$IFRX should go slowly 5$ + | frans | investorshub | 04/17/2023 6:53:22 PM |
$IFRX 4.2 now slowly on the move | frans | investorshub | 04/17/2023 4:47:27 PM |
in here at 4.10 | frans | investorshub | 04/17/2023 4:30:35 PM |
Still in downtrend and they will keep diluting | the_stockoracle | investorshub | 04/13/2023 4:10:45 PM |
I bought more 4.04 | enthalpy | investorshub | 04/13/2023 2:13:43 PM |
Couple of pennies are cloce enough | Gator44 | investorshub | 04/13/2023 1:14:49 PM |
Learn your charts lol $3.93 is the gap fill | the_stockoracle | investorshub | 04/13/2023 1:11:39 PM |
Gap filled boys and girls... Big boy buying today !!! | Gator44 | investorshub | 04/13/2023 1:03:33 PM |
dont think we will see 3.50s but it | peterus | investorshub | 04/13/2023 6:36:07 AM |
Whats your thoughts on it hitting 3.50? | enthalpy | investorshub | 04/13/2023 12:25:12 AM |
When it hits $3.93 tomorrow is where Ill | the_stockoracle | investorshub | 04/12/2023 5:13:41 PM |
Tomorrow we probably hit 3.75ish and that's close | enthalpy | investorshub | 04/12/2023 3:37:46 PM |
Probably right. I loaded some at 4.20 with | enthalpy | investorshub | 04/12/2023 3:35:25 PM |
beter on side line and buy bottom | peterus | investorshub | 04/12/2023 3:25:36 PM |
it wil but not today | peterus | investorshub | 04/12/2023 2:59:42 PM |
I thought you said going to $10 lol | the_stockoracle | investorshub | 04/12/2023 2:53:12 PM |
im still on side line | peterus | investorshub | 04/12/2023 2:38:10 PM |
I disagree Im going to be buying at | the_stockoracle | investorshub | 04/12/2023 2:35:45 PM |
4.40s 4.50s could be stronge support | peterus | investorshub | 04/12/2023 1:25:57 PM |
News, Short Squeeze, Breakout and More Instantly...
InflaRx N.V. Company Name:
IFRX Stock Symbol:
NASDAQ Market:
JENA, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biotechnology company pioneering anti-inflammatory therapeutics ...
JENA, Germany, April 24, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biotechnology company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in the Capital One Securities 1st Annual Biotech/Biopharma Disrupt...
InflaRx will focus development activities and resources initially on selected indications in immuno-dermatology, with registrational-phase vilobe...